Iain McGregor - Publications

Affiliations: 
Psychology University of Sydney, Camperdown, New South Wales, Australia 

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Reis ALM, Hammond JM, Stevanovski I, Arnold JC, McGregor IS, Deveson IW, Gururajan A. Sex-specific transcriptomic and epitranscriptomic signatures of PTSD-like fear acquisition. Iscience. 25: 104861. PMID 36039298 DOI: 10.1016/j.isci.2022.104861  0.654
2020 Gamage TF, Barrus DG, Kevin RC, Finlay DB, Lefever TW, Patel PR, Grabenauer MA, Glass M, McGregor IS, Wiley JL, Thomas BF. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Pharmacology, Biochemistry, and Behavior. 172918. PMID 32247816 DOI: 10.1016/J.Pbb.2020.172918  0.307
2018 Everett NA, McGregor IS, Baracz SJ, Cornish JL. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement. Neuropharmacology. PMID 29353054 DOI: 10.1016/j.neuropharm.2017.12.036  0.411
2017 Kevin RC, Wood KE, Stuart J, Mitchell AJ, Moir M, Banister SD, Kassiou M, McGregor IS. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. Journal of Psychopharmacology (Oxford, England). 269881116684336. PMID 28093016 DOI: 10.1177/0269881116684336  0.369
2017 Russell J, Maguire S, Kesby A, McGregor I, O’Dell A, Treasure J. Oxytocin as a Treatment Enhancer in Anorexia Nervosa European Psychiatry. 41: S37-S37. DOI: 10.1016/J.Eurpsy.2017.01.171  0.346
2016 Ramos L, Hicks C, Caminer A, Couto K, Narlawar R, Kassiou M, McGregor IS. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors. Pharmacology, Biochemistry, and Behavior. PMID 27725273 DOI: 10.1016/J.Pbb.2016.10.002  0.619
2016 Hicks C, Ramos L, Dampney B, Baracz SJ, McGregor IS, Hunt GE. Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059. Brain Research Bulletin. PMID 27725169 DOI: 10.1016/J.Brainresbull.2016.10.005  0.623
2015 Baracz SJ, Parker LM, Suraev AS, Everett NA, Goodchild AK, McGregor IS, Cornish JL. Chronic methamphetamine self-administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and subthalamic nucleus of the rat. Journal of Neuroendocrinology. PMID 26563756 DOI: 10.1111/Jne.12337  0.3
2015 Ramos L, Hicks C, Caminer A, Goodwin J, McGregor IS. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Psychopharmacology. 232: 2631-41. PMID 25772337 DOI: 10.1007/S00213-015-3899-9  0.542
2015 Hicks C, Ramos L, Reekie TA, Narlawar R, Kassiou M, McGregor IS. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology. 232: 2659-67. PMID 25761839 DOI: 10.1007/S00213-015-3902-5  0.578
2014 Hicks C, Cornish JL, Baracz SJ, Suraev A, McGregor IS. Adolescent pre-treatment with oxytocin protects against adult methamphetamine-seeking behavior in female rats. Addiction Biology. PMID 25402719 DOI: 10.1111/Adb.12197  0.616
2014 Baracz SJ, Everett NA, McGregor IS, Cornish JL. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats. Addiction Biology. PMID 25399704 DOI: 10.1111/adb.12198  0.409
2014 van Nieuwenhuijzen PS, McGregor IS, Chebib M, Hunt GE. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382. Neuroscience. 277: 700-15. PMID 25088910 DOI: 10.1016/j.neuroscience.2014.07.056  0.4
2014 Ramos L, Hicks C, Caminer A, McGregor IS. Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats. Psychoneuroendocrinology. 46: 46-51. PMID 24882157 DOI: 10.1016/J.Psyneuen.2014.04.013  0.627
2014 Bowen MT, McGregor IS. Oxytocin and vasopressin modulate the social response to threat: a preclinical study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1621-33. PMID 24807123 DOI: 10.1017/S1461145714000388  0.352
2014 Wong A, Keats K, Rooney K, Hicks C, Allsop DJ, Arnold JC, McGregor IS. Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences. Psychopharmacology. 231: 3987-96. PMID 24696079 DOI: 10.1007/S00213-014-3532-3  0.525
2014 Hicks C, Ramos L, Reekie T, Misagh GH, Narlawar R, Kassiou M, McGregor IS. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. British Journal of Pharmacology. 171: 2868-87. PMID 24641248 DOI: 10.1111/Bph.12613  0.599
2014 Suraev AS, Bowen MT, Ali SO, Hicks C, Ramos L, McGregor IS. Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood. Hormones and Behavior. 65: 488-96. PMID 24631584 DOI: 10.1016/J.Yhbeh.2014.03.002  0.608
2014 Bruno R, Allsop DJ, Copeland J, Lintzeris N, McGregor I, Norberg M, Dunlop A, Montebello M, Sadler C, Holland R, Rivas G. The impact of Sativex® on cognitive function during treatment for cannabis withdrawal Drug and Alcohol Dependence. 140: e22. DOI: 10.1016/J.Drugalcdep.2014.02.082  0.365
2013 Motbey CP, Clemens KJ, Apetz N, Winstock AR, Ramsey J, Li KM, Wyatt N, Callaghan PD, Bowen MT, Cornish JL, McGregor IS. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. Journal of Psychopharmacology (Oxford, England). 27: 823-36. PMID 23739178 DOI: 10.1177/0269881113490325  0.328
2013 Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M, McGregor IS. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2249-59. PMID 23676791 DOI: 10.1038/Npp.2013.125  0.653
2012 Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, Hicks C, Kendig MD, Wyatt N, Callaghan PD, McGregor IS. Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. Plos One. 7: e45473. PMID 23029034 DOI: 10.1371/Journal.Pone.0045473  0.595
2012 May MD, Bowen MT, McGregor IS, Timberlake W. Rubbings deposited by cats elicit defensive behavior in rats. Physiology & Behavior. 107: 711-8. PMID 22433389 DOI: 10.1016/J.Physbeh.2012.03.007  0.332
2012 Hicks C, Jorgensen W, Brown C, Fardell J, Koehbach J, Gruber CW, Kassiou M, Hunt GE, McGregor IS. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. Journal of Neuroendocrinology. 24: 1012-29. PMID 22420322 DOI: 10.1111/J.1365-2826.2012.02311.X  0.589
2012 Cornish JL, Hunt GE, Robins L, McGregor IS. Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience. 206: 100-14. PMID 22266344 DOI: 10.1016/j.neuroscience.2012.01.004  0.328
2012 Wong A, Gunasekaran N, Hancock DP, Denyer GS, Meng L, Radford JL, McGregor IS, Arnold JC. The major plant-derived cannabinoid Δ(9)-tetrahydrocannabinol promotes hypertrophy and macrophage infiltration in adipose tissue. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 44: 105-13. PMID 22189757 DOI: 10.1055/S-0031-1297940  0.334
2012 Baracz SJ, Rourke PI, Pardey MC, Hunt GE, McGregor IS, Cornish JL. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behavioural Brain Research. 228: 185-93. PMID 22155611 DOI: 10.1016/j.bbr.2011.11.038  0.395
2012 Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addiction Biology. 17: 409-22. PMID 21995495 DOI: 10.1111/j.1369-1600.2011.00384.x  0.375
2011 Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. Plos One. 6: e27237. PMID 22110618 DOI: 10.1371/journal.pone.0027237  0.385
2011 Hunt GE, McGregor IS, Cornish JL, Callaghan PD. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Research Bulletin. 86: 65-73. PMID 21745546 DOI: 10.1016/j.brainresbull.2011.06.011  0.315
2011 Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology. 218: 443-57. PMID 21667074 DOI: 10.1007/s00213-011-2342-0  0.372
2011 Verty AN, Evetts MJ, Crouch GJ, McGregor IS, Stefanidis A, Oldfield BJ. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1349-58. PMID 21412227 DOI: 10.1038/npp.2011.19  0.757
2010 Arnold JC, Dielenberg RA, McGregor IS. Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety. Life Sciences. 87: 572-8. PMID 20875432 DOI: 10.1016/j.lfs.2010.09.018  0.31
2010 Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, Boucher AA, McGregor IS. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology. 15: 448-63. PMID 20731630 DOI: 10.1111/j.1369-1600.2010.00247.x  0.389
2010 van Nieuwenhuijzen PS, Long LE, Hunt GE, Arnold JC, McGregor IS. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology. 212: 663-74. PMID 20730418 DOI: 10.1007/s00213-010-1986-5  0.342
2010 Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor IS. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology. 58: 38-43. PMID 19560473 DOI: 10.1016/j.neuropharm.2009.06.018  0.37
2009 van Nieuwenhuijzen PS, Li KM, Hunt GE, McGregor IS. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats. Neuropsychobiology. 60: 195-203. PMID 19893336 DOI: 10.1159/000253555  0.348
2009 Gunasekaran N, Long LE, Dawson BL, Hansen GH, Richardson DP, Li KM, Arnold JC, McGregor IS. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology. 158: 1330-7. PMID 19681888 DOI: 10.1111/j.1476-5381.2009.00399.x  0.312
2009 Verty AN, Boon WM, Mallet PE, McGregor IS, Oldfield BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16. PMID 19490094 DOI: 10.1111/j.1460-9568.2009.06750.x  0.783
2009 van Nieuwenhuijzen PS, McGregor IS. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. Drug and Alcohol Dependence. 103: 137-47. PMID 19446408 DOI: 10.1016/j.drugalcdep.2009.03.004  0.352
2009 van Nieuwenhuijzen PS, McGregor IS, Hunt GE. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen. Neuroscience. 158: 441-55. PMID 18996447 DOI: 10.1016/j.neuroscience.2008.10.011  0.359
2008 Thompson MR, Callaghan PD, Hunt GE, McGregor IS. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1013-21. PMID 18302974 DOI: 10.1016/j.pnpbp.2008.01.014  0.37
2008 Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1113-26. PMID 17581536 DOI: 10.1038/sj.npp.1301475  0.696
2007 Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience. 146: 509-14. PMID 17383105 DOI: 10.1016/j.neuroscience.2007.02.032  0.315
2007 Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, van Nieuwenhuyzen P, Hu P. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation (New York, N.Y. : 1994). 14: 63-76. PMID 17365662 DOI: 10.1080/10739680601073451  0.314
2007 Clemens KJ, Cornish JL, Hunt GE, McGregor IS. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug and Alcohol Dependence. 86: 183-90. PMID 16884865 DOI: 10.1016/j.drugalcdep.2006.06.004  0.374
2006 Clemens KJ, Cornish JL, Hunt GE, McGregor IS. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. Pharmacology, Biochemistry, and Behavior. 85: 454-63. PMID 17112571 DOI: 10.1016/j.pbb.2006.09.015  0.319
2006 O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology (Oxford, England). 20: 611-21. PMID 16714325 DOI: 10.1177/0269881106065188  0.737
2006 Singh ME, McGregor IS, Mallet PE. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 58-69. PMID 15920503 DOI: 10.1038/Sj.Npp.1300770  0.811
2005 Young JM, McGregor IS, Mallet PE. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1475-82. PMID 16178074 DOI: 10.1038/Sj.Npp.1300692  0.727
2005 Singh ME, McGregor IS, Mallet PE. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology. 49: 1189-200. PMID 16137723 DOI: 10.1016/J.Neuropharm.2005.07.008  0.814
2005 Verty AN, McGregor IS, Mallet PE. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9. PMID 16098995 DOI: 10.1016/J.Neuropharm.2005.03.025  0.819
2005 Cornish JL, Lontos JM, Clemens KJ, McGregor IS. Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors. Psychopharmacology. 180: 21-32. PMID 15682301 DOI: 10.1007/s00213-004-2135-9  0.344
2005 McGregor IS, Dam KD, Mallet PE, Gallate JE. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 35-45. PMID 15550450 DOI: 10.1093/Alcalc/Agh113  0.74
2005 McGregor I, Clemens K, Cornish J, Thompson M, Li K, Hunt G. S33 MDMA, METHAMPHETAMINE AND THEIR COMBINATION: COMPARISON OF LONG-TERM BEHAVIOURAL AND NEURAL EFFECTS IN RATS Behavioural Pharmacology. 16: S11. DOI: 10.1097/00008877-200509001-00033  0.338
2004 O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology (Oxford, England). 18: 502-8. PMID 15582916 DOI: 10.1177/0269881104047277  0.779
2004 Singh ME, Verty AN, Price I, McGregor IS, Mallet PE. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69. PMID 15567425 DOI: 10.1016/J.Neuropharm.2004.08.008  0.788
2004 Morley KC, Cornish JL, Li KM, McGregor IS. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats. Pharmacology, Biochemistry, and Behavior. 79: 331-42. PMID 15501310 DOI: 10.1016/j.pbb.2004.08.004  0.345
2004 Singh ME, Verty AN, McGregor IS, Mallet PE. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research. 1026: 244-53. PMID 15488486 DOI: 10.1016/J.Brainres.2004.08.027  0.792
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 47: 593-603. PMID 15380376 DOI: 10.1016/J.Neuropharm.2004.06.002  0.802
2004 Verty AN, McGregor IS, Mallet PE. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Research. 1020: 188-95. PMID 15312802 DOI: 10.1016/J.Brainres.2004.06.033  0.815
2004 Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. Neuropharmacology. 46: 954-65. PMID 15081792 DOI: 10.1016/J.Neuropharm.2004.01.002  0.708
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology. 145: 3224-31. PMID 15033920 DOI: 10.1210/En.2004-0059  0.808
2004 Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology. 173: 318-25. PMID 15029472 DOI: 10.1007/s00213-004-1786-x  0.318
2004 Verty AN, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354: 217-20. PMID 14700735 DOI: 10.1016/J.Neulet.2003.10.035  0.796
2004 Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology. 173: 210-6. PMID 14663553 DOI: 10.1007/S00213-003-1694-5  0.727
2004 Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 694-704. PMID 14627999 DOI: 10.1038/sj.npp.1300347  0.329
2003 McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM, Cornish JL, Hunt GE. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology. 168: 465-74. PMID 12700882 DOI: 10.1007/s00213-003-1452-8  0.309
2003 Verty AN, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168: 314-23. PMID 12700881 DOI: 10.1007/S00213-003-1451-9  0.794
2003 Norwood CS, Cornish JL, Mallet PE, McGregor IS. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. European Journal of Pharmacology. 465: 105-14. PMID 12650839 DOI: 10.1016/S0014-2999(03)01455-9  0.754
2003 Allen KV, McGregor IS, Hunt GE, Singh ME, Mallet PE. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. Neuropharmacology. 44: 264-74. PMID 12623225 DOI: 10.1016/S0028-3908(02)00364-7  0.813
2003 Gallate JE, Morley KC, Ambermoon P, McGregor IS. The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety. Psychopharmacology. 166: 51-60. PMID 12474111 DOI: 10.1007/s00213-002-1291-z  0.327
2002 Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. European Journal of Pharmacology. 446: 89-96. PMID 12098589  0.331
2002 McGregor IS, Schrama L, Ambermoon P, Dielenberg RA. Not all 'predator odours' are equal: cat odour but not 2,4,5 trimethylthiazoline (TMT; fox odour) elicits specific defensive behaviours in rats. Behavioural Brain Research. 129: 1-16. PMID 11809490  0.33
2001 Arnold JC, Hunt GE, McGregor IS. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sciences. 70: 97-108. PMID 11764010 DOI: 10.1016/S0024-3205(01)01366-2  0.329
2001 Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology. 433: 91-9. PMID 11755138 DOI: 10.1016/S0014-2999(01)01512-6  0.713
2001 Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Research. 921: 240-55. PMID 11720732 DOI: 10.1016/S0006-8993(01)03127-4  0.731
2001 Dielenberg RA, Hunt GE, McGregor IS. "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience. 104: 1085-97. PMID 11457592  0.312
1999 Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology. 370: 233-40. PMID 10334497 DOI: 10.1016/S0014-2999(99)00170-3  0.74
1999 Gallate JE, McGregor IS. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology. 142: 302-8. PMID 10208323  0.396
1999 McGregor IS, Saharov T, Hunt GE, Topple AN. Beer consumption in rats: the influence of ethanol content, food deprivation, and cocaine. Alcohol (Fayetteville, N.Y.). 17: 47-56. PMID 9895037  0.302
1998 Topple AN, Hunt GE, McGregor IS. Possible neural substrates of beer-craving in rats. Neuroscience Letters. 252: 99-102. PMID 9756331  0.306
1998 McGregor IS, Arnold JC, Weber MF, Topple AN, Hunt GE. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. Brain Research. 802: 19-26. PMID 9748483 DOI: 10.1016/S0006-8993(98)00549-6  0.375
1998 Arnold JC, Topple AN, Hunt GE, McGregor IS. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. European Journal of Pharmacology. 354: 9-16. PMID 9726625 DOI: 10.1016/S0014-2999(98)00433-6  0.302
1996 McGregor IS, Dastur FN, McLellan RA, Brown RE. Cannabinoid modulation of rat pup ultrasonic vocalizations. European Journal of Pharmacology. 313: 43-9. PMID 8905327 DOI: 10.1016/0014-2999(96)00511-0  0.503
1994 McGregor IS, Lee AM, Westbrook RF. Stress-induced changes in respiratory quotient, energy expenditure and locomotor activity in rats: effects of midazolam. Psychopharmacology. 116: 475-82. PMID 7701052 DOI: 10.1007/BF02247481  0.301
Show low-probability matches.